Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids

Denise Wootten, John Simms, Cassandra Koole, Owen L Woodman, Roger J Summers, Arthur Christopoulos, Patrick M Sexton

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The glucagon-like peptide 1 receptor (GLP-1R) is a promising target for the treatment of type II diabetes mellitus because of its role in metabolic homeostasis. In recent years, difficulties with peptide therapies have driven the search for small-molecule compounds to modulate the activity of this receptor. We recently identified quercetin, a naturally occurring flavonoid, as a probe-dependent, pathway-selective allosteric modulator of GLP-1R-mediated signaling. Using Chinese hamster ovary cells expressing the human GLP-1R, we have now extended this work to identify the structural requirements of flavonoids to modify GLP-1R binding and signaling (cAMP formation and intracellular Ca(2+) mobilization) of each of the GLP-1R endogenous agonists, as well as the clinically used exogenous peptide mimetic exendin-4. This study identified a chemical series of hydroxyl flavonols with the ability to selectively augment calcium (Ca(2+)) signaling in a peptide agonist-specific manner, with effects only on truncated GLP-1 peptides [GLP-1(7-36)NH(2) and GLP-1(7-37)] and exendin-4, but not on oxyntomodulin or full-length GLP-1 peptides [GLP-1(1-36)NH(2) and GLP-1(1-37)]. In addition, the 3-hydroxyl group on the flavone backbone (i.e., a flavonol) was essential for this activity, however insufficient on its own, to produce the allosteric effects. In contrast to hydroxyl flavonols, catechin had no effect on peptide-mediated Ca(2+) signaling but negatively modulated peptide-mediated cAMP formation in a probe-dependent manner. These data represent a detailed examination of the action of different flavonoids on peptide agonists at the GLP-1R and may aid in the development of future small molecule compounds targeted at this receptor.

Original languageEnglish
Pages (from-to)540-550
Number of pages11
JournalThe Journal of pharmacology and experimental therapeutics
Volume336
Issue number2
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Flavonoids
Glucagon-Like Peptide 1
Peptides
Hydroxyl Radical
Flavonols
flavone
Oxyntomodulin
Glucagon-Like Peptide-1 Receptor
Catechin
Quercetin
Cricetulus
Type 2 Diabetes Mellitus
Ovary
Homeostasis
Calcium

Keywords

  • 3T3 Cells
  • Animals
  • CHO Cells
  • Calcium Signaling
  • Catechin
  • Cricetinae
  • Cricetulus
  • Flavonoids
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Mice
  • Receptors, Glucagon
  • Signal Transduction
  • Structure-Activity Relationship
  • Journal Article
  • Research Support, Non-U.S. Gov't

Cite this

Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids. / Wootten, Denise; Simms, John; Koole, Cassandra; Woodman, Owen L; Summers, Roger J; Christopoulos, Arthur; Sexton, Patrick M.

In: The Journal of pharmacology and experimental therapeutics, Vol. 336, No. 2, 02.2011, p. 540-550.

Research output: Contribution to journalArticle

Wootten, Denise ; Simms, John ; Koole, Cassandra ; Woodman, Owen L ; Summers, Roger J ; Christopoulos, Arthur ; Sexton, Patrick M. / Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids. In: The Journal of pharmacology and experimental therapeutics. 2011 ; Vol. 336, No. 2. pp. 540-550.
@article{76540ebcea50467b9ef637ac85c8eccf,
title = "Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids",
abstract = "The glucagon-like peptide 1 receptor (GLP-1R) is a promising target for the treatment of type II diabetes mellitus because of its role in metabolic homeostasis. In recent years, difficulties with peptide therapies have driven the search for small-molecule compounds to modulate the activity of this receptor. We recently identified quercetin, a naturally occurring flavonoid, as a probe-dependent, pathway-selective allosteric modulator of GLP-1R-mediated signaling. Using Chinese hamster ovary cells expressing the human GLP-1R, we have now extended this work to identify the structural requirements of flavonoids to modify GLP-1R binding and signaling (cAMP formation and intracellular Ca(2+) mobilization) of each of the GLP-1R endogenous agonists, as well as the clinically used exogenous peptide mimetic exendin-4. This study identified a chemical series of hydroxyl flavonols with the ability to selectively augment calcium (Ca(2+)) signaling in a peptide agonist-specific manner, with effects only on truncated GLP-1 peptides [GLP-1(7-36)NH(2) and GLP-1(7-37)] and exendin-4, but not on oxyntomodulin or full-length GLP-1 peptides [GLP-1(1-36)NH(2) and GLP-1(1-37)]. In addition, the 3-hydroxyl group on the flavone backbone (i.e., a flavonol) was essential for this activity, however insufficient on its own, to produce the allosteric effects. In contrast to hydroxyl flavonols, catechin had no effect on peptide-mediated Ca(2+) signaling but negatively modulated peptide-mediated cAMP formation in a probe-dependent manner. These data represent a detailed examination of the action of different flavonoids on peptide agonists at the GLP-1R and may aid in the development of future small molecule compounds targeted at this receptor.",
keywords = "3T3 Cells, Animals, CHO Cells, Calcium Signaling, Catechin, Cricetinae, Cricetulus, Flavonoids, Glucagon-Like Peptide-1 Receptor, Humans, Mice, Receptors, Glucagon, Signal Transduction, Structure-Activity Relationship, Journal Article, Research Support, Non-U.S. Gov't",
author = "Denise Wootten and John Simms and Cassandra Koole and Woodman, {Owen L} and Summers, {Roger J} and Arthur Christopoulos and Sexton, {Patrick M}",
year = "2011",
month = "2",
doi = "10.1124/jpet.110.176362",
language = "English",
volume = "336",
pages = "540--550",
journal = "The Journal of pharmacology and experimental therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids

AU - Wootten, Denise

AU - Simms, John

AU - Koole, Cassandra

AU - Woodman, Owen L

AU - Summers, Roger J

AU - Christopoulos, Arthur

AU - Sexton, Patrick M

PY - 2011/2

Y1 - 2011/2

N2 - The glucagon-like peptide 1 receptor (GLP-1R) is a promising target for the treatment of type II diabetes mellitus because of its role in metabolic homeostasis. In recent years, difficulties with peptide therapies have driven the search for small-molecule compounds to modulate the activity of this receptor. We recently identified quercetin, a naturally occurring flavonoid, as a probe-dependent, pathway-selective allosteric modulator of GLP-1R-mediated signaling. Using Chinese hamster ovary cells expressing the human GLP-1R, we have now extended this work to identify the structural requirements of flavonoids to modify GLP-1R binding and signaling (cAMP formation and intracellular Ca(2+) mobilization) of each of the GLP-1R endogenous agonists, as well as the clinically used exogenous peptide mimetic exendin-4. This study identified a chemical series of hydroxyl flavonols with the ability to selectively augment calcium (Ca(2+)) signaling in a peptide agonist-specific manner, with effects only on truncated GLP-1 peptides [GLP-1(7-36)NH(2) and GLP-1(7-37)] and exendin-4, but not on oxyntomodulin or full-length GLP-1 peptides [GLP-1(1-36)NH(2) and GLP-1(1-37)]. In addition, the 3-hydroxyl group on the flavone backbone (i.e., a flavonol) was essential for this activity, however insufficient on its own, to produce the allosteric effects. In contrast to hydroxyl flavonols, catechin had no effect on peptide-mediated Ca(2+) signaling but negatively modulated peptide-mediated cAMP formation in a probe-dependent manner. These data represent a detailed examination of the action of different flavonoids on peptide agonists at the GLP-1R and may aid in the development of future small molecule compounds targeted at this receptor.

AB - The glucagon-like peptide 1 receptor (GLP-1R) is a promising target for the treatment of type II diabetes mellitus because of its role in metabolic homeostasis. In recent years, difficulties with peptide therapies have driven the search for small-molecule compounds to modulate the activity of this receptor. We recently identified quercetin, a naturally occurring flavonoid, as a probe-dependent, pathway-selective allosteric modulator of GLP-1R-mediated signaling. Using Chinese hamster ovary cells expressing the human GLP-1R, we have now extended this work to identify the structural requirements of flavonoids to modify GLP-1R binding and signaling (cAMP formation and intracellular Ca(2+) mobilization) of each of the GLP-1R endogenous agonists, as well as the clinically used exogenous peptide mimetic exendin-4. This study identified a chemical series of hydroxyl flavonols with the ability to selectively augment calcium (Ca(2+)) signaling in a peptide agonist-specific manner, with effects only on truncated GLP-1 peptides [GLP-1(7-36)NH(2) and GLP-1(7-37)] and exendin-4, but not on oxyntomodulin or full-length GLP-1 peptides [GLP-1(1-36)NH(2) and GLP-1(1-37)]. In addition, the 3-hydroxyl group on the flavone backbone (i.e., a flavonol) was essential for this activity, however insufficient on its own, to produce the allosteric effects. In contrast to hydroxyl flavonols, catechin had no effect on peptide-mediated Ca(2+) signaling but negatively modulated peptide-mediated cAMP formation in a probe-dependent manner. These data represent a detailed examination of the action of different flavonoids on peptide agonists at the GLP-1R and may aid in the development of future small molecule compounds targeted at this receptor.

KW - 3T3 Cells

KW - Animals

KW - CHO Cells

KW - Calcium Signaling

KW - Catechin

KW - Cricetinae

KW - Cricetulus

KW - Flavonoids

KW - Glucagon-Like Peptide-1 Receptor

KW - Humans

KW - Mice

KW - Receptors, Glucagon

KW - Signal Transduction

KW - Structure-Activity Relationship

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1124/jpet.110.176362

DO - 10.1124/jpet.110.176362

M3 - Article

VL - 336

SP - 540

EP - 550

JO - The Journal of pharmacology and experimental therapeutics

JF - The Journal of pharmacology and experimental therapeutics

SN - 0022-3565

IS - 2

ER -